P.A.W. Capital Corp Bristol Myers Squibb CO Transaction History

P.A.W. Capital Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 13, 2022	SELL	$72.62 - $79.98 $72,620 - $79,980	-1,000 Reduced 7.69%	12,000 $924,000
Q1 2022 Apr 21, 2022	SELL	$61.48 - $73.72 $122,960 - $147,440	-2,000 Reduced 13.33%	13,000 $949,000
Q4 2021 Feb 10, 2022	BUY	$53.63 - $62.52 $160,890 - $187,560	3,000 Added 25.0%	15,000 $935,000
Q3 2021 Oct 25, 2021	BUY	$59.17 - $69.31 $710,040 - $831,720	12,000 New	12,000 $710,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of P.A.W. Capital Corp, based on Form 13F filings with the SEC.

Stay updated on P.A.W. Capital Corp with notifications on news.